LOGIN
ID
PW
MemberShip
2025-07-21 04:21
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
Input Time : 2019-12-23
[Download file]
go back
OPINION
[Reporter's View] Bio policy should remain consistent
Reporter's view |
Kim, Jin-Gu
[Reporter's View] Gov¡¯t cooperation leads to a price cut?
Reporter's view |
Eo, Yun-Ho
[Reporter¡¯s View]Biotech¡¯s responsible approach to failure
Reporter's view |
Cha, Jihyun
INTERVIEW
V-olet challenges to become a blockbuster fat-destroying inj
Kim Seul-ki, PM of Daewoong Pharmaceutical's Nabota Business Team
'Viatris will lead market with innovation and leadership'
Bill Schuster, Representative Director & Country Manager of Viatris Korea
"Livtencity offers new CMV trt for transplant patients"
Dr. Sang-Oh Lee, professor at Seoul Asan Medical Center's Department of Infectious Diseases
¡®SGLT2i+TZD promising for diabetics with fatty liver risk¡¯
Cheol-Young Park, Professor of Endocrinology at Kangbuk Samsung Hospital
Hemlibra shows long-term efficacy and safety in hemophilia
Long-term prevention of bleeding episodes
Data
Roche 2018 Annualreport
Roche 2018 Annualreport
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
MOST READ
1
Jung Eun-kyung views "orphan disease fund establishment"
2
[Reporter's View] A separate fund for new orphan drugs
3
Denmark's non-profit foundation's virtuous governance cycle
4
Will the external reference pricing reevals gain momentum?